Nov 14, 2024 / 08:30AM GMT
Operator
Welcome to BioArctic Q3 report 2024.
(Operator instructions).
I will hand the conference over to CEO Gunilla Osswald and CFO Anders Martin-Löf. Please go ahead.
Gunilla Osswald - BioArctic - CEO
Good morning and welcome to BioArctic presentation for the third quarter of 2024.
I have three key messages for today. The first one is that our projects are progressing very well, and I'm really excited about our BrainTransporter technology, where we now have been presenting data publicly and I will show some of those data here today. Our project for Parkinson's disease has initiated Phase two A with screening of patients. My second message is that Leqembi sales are increasing, resulting in over 60% higher royalties for us, compared to previous quarter. The market in the US continues to grow and Japan and China are above expectations, and the regulatory process continues, and we are eagerly awaiting CHMP opinion tomorrow. The third message is that we have a solid financial situation so we can focus on progressing our projects in a good way.
Q3 2024 BioArctic AB Earnings Call(Q&A-session) Transcript
Nov 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers